Surgical Hub

Tenectase 20mg Injection belongs to a group of medicines called thrombolytic agents. It is used in the emergency treatment of ischemic stroke, which occurs when a blood vessel to your brain becomes blocked by a blood clot. This medicine helps to dissolve the clot and restore blood flow to your brain.

Pemetrexed 500 mg is an antifolate chemotherapy medication used primarily to treat specific cancers of the lungs and chest. It works by blocking enzymes essential for DNA and RNA synthesis, which stops cancer cells from growing and dividing. Primary Uses

• Non-Small Cell Lung Cancer (NSCLC): Used alone or in combination with other drugs (like cisplatin or pembrolizumab) for advanced or metastatic non-squamous NSCLC.
• Malignant Pleural Mesothelioma: A first-line treatment, typically combined with cisplatin, for this rare cancer affecting the lining of the lungs. 

Administration and Supportive Care 

• Method: Administered as an intravenous (IV) infusion over approximately 10 minutes by a healthcare professional in a clinical setting.
• Cycle: Usually given once every 21 days (3-week cycle).
• Required Supplements: To reduce severe toxicity, patients must take folic acid daily and receive vitamin B12 injections (every 9 weeks).
• Rash Prevention: A corticosteroid (like dexamethasone) is typically prescribed for three days, starting the day before treatment, to prevent skin rashes. 

Common Side EffectsMost side effects are manageable but require close monitoring: 

• Hematologic: Low white blood cells (increased infection risk), low red blood cells (anemia/fatigue), and low platelets (bruising/bleeding).
• Gastrointestinal: Nausea, vomiting, diarrhea, constipation, and loss of appetite.
• Other: Mouth sores (stomatitis), skin rash, and temporary hair thinning or loss

Docetaxel is a chemotherapy drug administered intravenously and used to treat several types of cancer, including breast, lung, prostate, stomach, and head and neck cancers. The drug works by disrupting the division of cancer cells. Due to potential side effects such as neutropenia, fluid retention, and nerve issues, patients receiving docetaxel require regular monitoring. The dosage is determined by a healthcare professional based on the individual patient's condition and tolerance.       Uses

• Breast Cancer: Used for advanced, metastatic, or as adjuvant treatment.
• Lung Cancer: Effective against non-small cell lung cancer (NSCLC).
• Prostate Cancer: Treats metastatic castration-resistant prostate cancer.
• Stomach Cancer: Used for advanced gastric or gastroesophageal junction cancer.
• Head & Neck Cancers:. 

How it Works

• Docetaxel is a member of the taxane class of chemotherapy drugs.
• It interferes with the function of microtubules, which are necessary for cancer cell division, thereby slowing growth and causing cell death. 

Common Side Effects & Risks

• Blood-related: Can lead to low white blood cells (neutropenia), anemia, and an increased risk of infection.
• Fluid Retention: May cause swelling (edema) in the limbs and potentially generalized fluid buildup.
• Neurological: Possible side effects include tingling (paresthesia), weakness, and nerve pain.
• Skin: May cause redness and peeling on the hands and feet.
• Other: Nausea, hair loss, fatigue, muscle pain, nail changes, and hypersensitivity reactions (such as flushing, rash, and difficulty breathing) can occur. 

Etoposide 100 mg injection is a potent chemotherapy medication used primarily to treat various forms of cancer, including small cell lung cancer and testicular cancer. It is a cytotoxic agent that works by inhibiting the enzyme topoisomerase II, which is essential for DNA multiplication in cancer cells; this action slows tumor growth and eventually leads to cell death. Common UsesBeyond lung and testicular cancers, etoposide may be prescribed for: 

• Blood Cancers: Acute myeloid leukemia (AML), Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma.
• Other Malignancies: Ovarian cancer, neuroblastoma, and gestational trophoblastic neoplasia. 

Administration and Dosage

• Professional Administration: It must be administered as a slow intravenous (IV) infusion over 30 to 60 minutes by a healthcare professional. Rapid injection can cause a sudden drop in blood pressure.
• Dosage: The exact dose is calculated based on body surface area (mg/m²) and the patient's specific condition. 

Side EffectsEtoposide can cause significant side effects that require medical monitoring: 

• Blood Disorders: Myelosuppression (low white blood cell, red blood cell, and platelet counts), which increases infection and bleeding risks.
• Gastrointestinal: Nausea, vomiting, diarrhea, loss of appetite, and mouth sores (stomatitis).
• General: Temporary hair loss (alopecia), fatigue, and weakness.
• Severe Reactions: Allergic reactions (swelling, breathing difficulty) and liver toxicity. 

Safety and Monitoring

• Pregnancy/Breastfeeding: Generally unsafe as it can harm a fetus or nursing infant. Effective contraception is required during and for at least 6 months after treatment for both men and women.
• Regular Testing: Doctors will monitor blood cell counts, liver function, and kidney function throughout the treatment course.
• Interactions: It may interact with alcohol, live vaccines, and other medications like blood thinners (warfarin) or certain anti-seizure drugs. 

For detailed patient assistance, you may refer to resources like the NCBI Stat

Gemcitabine is a chemotherapy medication, classified as an antimetabolite, primarily used to treat various solid tumors by slowing or stopping the growth of cancer cells. It is commonly marketed under the brand names Gemzar and Infugem. Common Uses (Indications)Gemcitabine is FDA-approved for the treatment of several types of cancer, often as a first or second-line therapy: 

• Pancreatic Cancer: Used alone as a first-line treatment.
• Breast Cancer: Used in combination with paclitaxel for metastatic cases.
• Non-Small Cell Lung Cancer (NSCLC): Used in combination with cisplatin for advanced or inoperable cases.
• Ovarian Cancer: Used in combination with carboplatin for advanced cases that have returned after previous treatment.
• Bladder Cancer: Often used with cisplatin for metastatic disease (off-label in some contexts). 

Administration and Dosage 

• Method: Administered exclusively via intravenous (IV) infusion by healthcare professionals in a hospital or clinic setting.
• Duration: Typically given over 30 minutes. Prolonging the infusion beyond 60 minutes can significantly increase toxicity.
• Schedule: Dosing schedules vary by cancer type, typically following 21-day or 28-day cycles. 

Side Effects and PrecautionsAs with most chemotherapy, Gemcitabine affects healthy cells as well as cancer cells. 

• Common Side Effects: Nausea, vomiting, fatigue, flu-like symptoms (fever, chills), hair thinning/loss, and temporary liver or kidney function changes.
• Myelosuppression: A major dose-limiting toxicity where bone marrow function decreases, leading to low red blood cells (anemia), white blood cells (increased infection risk), and platelets (bruising/bleeding risk).
• Serious Warnings:
  • Pulmonary Toxicity: Can cause severe lung conditions like pulmonary edema or respiratory failure.
  • Vascular/Nervous System: Rare risks include Capillary Leak Syndrome (CLS) and Posterior Reversible Encephalopathy Syndrome (PRES).
• Pregnancy & Fertility: It can cause fetal harm; effective contraception is recommended for both men and women during and for several months after treatment. 

Bleomycin is a potent anticancer antibiotic medication that stops cancer cells from growing by causing breaks in their DNA. It is used in chemotherapy regimens for various cancers and is often known by the brand name Blenoxane. Uses and IndicationsBleomycin is used either alone or in combination with other agents for the treatment of several malignancies: 

• Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma
• Testicular Carcinoma: Including embryonal cell, choriocarcinoma, and teratocarcinoma
• Squamous Cell Carcinoma: Cancers of the head and neck, penis, cervix, and vulva
• Malignant Pleural Effusion: It is used as a sclerosing agent to treat and prevent the recurrence of fluid accumulation around the lungs caused by cancer 

Administration and DosageBleomycin is administered in a hospital or clinical setting under the supervision of a qualified healthcare professional. 

• Routes: It can be given intravenously (into a vein), intramuscularly (into a muscle), subcutaneously (under the skin), or intrapleurally (into the chest cavity).
• Dosage: Dosing varies by the type of cancer and patient factors. For lymphoma patients, initial low doses are sometimes used to test for an allergic reaction. A lifetime cumulative dose over 400 units should be avoided due to the increased risk of pulmonary toxicity. 

Key Side Effects and PrecautionsThe most serious side effect of Bleomycin is lung damage, which can be life-threatening. 

• Severe Pulmonary Toxicity: The primary risk is pneumonitis, which can progress to irreversible pulmonary fibrosis (scarring of the lungs). This risk increases with age, cumulative dose, and supplemental oxygen administration during surgery. Regular monitoring of lung function (e.g., chest X-rays, DLCO tests) is essential.
• Idiosyncratic Reactions: Approximately 1% of lymphoma patients may experience a severe, anaphylaxis-like reaction, usually after the first or second dose, involving low blood pressure, confusion, fever, chills, and wheezing.
• Common Side Effects: Fever and chills, nausea, vomiting, loss of appetite, skin changes (darkening, rash, thickening), hair loss, and mouth sores.
• Pregnancy and Breastfeeding: It is not recommended during pregnancy as it can harm the fetus, and patients are advised to use effective birth control during treatment. 

Gemcitabine is a chemotherapy medication classified as an antimetabolite, primarily used to treat various solid tumors. It is often supplied in vials containing 1400 mg (1.4 g) of the drug, which is a common presentation in clinical settings. 1. Common Uses (Indications)Gemcitabine is utilized in the treatment of several types of cancer, frequently in combination with other therapeutic agents: 

• Pancreatic Cancer: It serves as a treatment option for advanced or metastatic disease.
• Non-Small Cell Lung Cancer (NSCLC): Often administered alongside cisplatin.
• Breast Cancer: Typically combined with paclitaxel for metastatic cases.
• Ovarian Cancer: Used in conjunction with carboplatin for recurrent advanced cases.
• Bladder Cancer: Frequently used with cisplatin. 

2. Administration

• Method: Gemcitabine is administered by healthcare professionals as an intravenous (IV) infusion over a specific duration.
• Storage: Most formulations should be stored at a controlled room temperature (20°C to 25°C) and should not be refrigerated or frozen. 

3. Key Side EffectsGemcitabine can lead to a decrease in blood cell counts, necessitating regular monitoring through blood tests before each administration. 

• Common: Nausea, vomiting, hair loss or thinning, fatigue, and flu-like symptoms such as fever and chills are frequently reported.
• Serious:
  • Myelosuppression: This involves low white blood cell counts, increasing the risk of infection, and low platelet counts, which can lead to bleeding or bruising.
  • Pulmonary Toxicity: Patients may experience shortness of breath or wheezing.
  • Liver/Kidney Stress: Monitoring of liver enzymes and renal function is a mandatory part of the treatment protocol. 

Oxaliplatin injection is a platinum-based chemotherapy medication used to treat various stages of colon and rectal cancer. It is typically administered as part of a combination regimen known as FOLFOX, which includes 5-fluorouracil (5-FU) and leucovorin. Primary Uses

• Adjuvant Treatment: Used to prevent cancer from returning in patients with Stage III colon cancer who have already had surgery to remove the primary tumor.
• Advanced Colorectal Cancer: Used to treat metastatic cancer (cancer that has spread).
• Other Off-label Uses: Sometimes used for stomach, pancreatic, or esophageal cancers. 

How It is Administered

• Method: It is given as a slow intravenous (IV) infusion into a vein, often through a central line or PICC line.
• Duration: Each infusion typically takes between 2 to 6 hours.
• Schedule: It is usually administered once every 14 days (2-week cycles). 

Key Warnings & Side Effects

• Cold Sensitivity: A unique side effect where exposure to cold temperatures, cold drinks, or cold objects can trigger tingling, numbness, or throat tightness. Patients are advised to avoid cold items for several days after treatment.
• Peripheral Neuropathy: Numbness, tingling, or pain in the hands and feet. This can be acute (temporary) or chronic (long-lasting).
• Allergic Reactions: Severe, potentially fatal allergic reactions (anaphylaxis) can occur within minutes of administration.
• Myelosuppression: It can lower blood cell counts, increasing the risk of infection, anemia, and bleeding.
• Common Symptoms: Nausea, vomiting, diarrhea, fatigue, and mouth sores. 

Dacarbazine injection is a chemotherapy medication primarily used to treat metastatic malignant melanoma and Hodgkin’s lymphoma. Classified as an alkylating agent, it works by damaging the DNA of cancer cells to stop them from growing and dividing. Common Uses

• Malignant Melanoma: Used alone or with other drugs to treat advanced skin cancer that has spread.
• Hodgkin’s Disease: Often used as second-line therapy in combination with drugs like doxorubicin, bleomycin, and vinblastine (the ABVD regimen).
• Off-label Uses: Sometimes prescribed for soft tissue sarcomas, neuroblastoma, and islet cell carcinoma of the pancreas. 

Administration and DosageDacarbazine is administered intravenously (IV) by healthcare professionals in a hospital or clinic setting. 

• Forms: Available as a lyophilized powder (usually 100 mg, 200 mg, or 500 mg vials) that must be reconstituted.
• Method: Can be given as a slow IV injection over 1 minute or as a short-term IV infusion over 15 to 30 minutes.
• Schedules: Typical regimens include daily doses for 5–10 days repeated every 3–4 weeks, or a larger single dose every 3 weeks. 

Key Warnings and Side Effects

• Hemopoietic Depression: The most common serious toxicity, causing a drop in white blood cells and platelets, which increases the risk of infection and bleeding.
• Liver Toxicity: Rarely, it can cause severe liver damage, including hepatic vein thrombosis (Budd-Chiari syndrome).
• Gastrointestinal Effects: Over 90% of patients experience nausea and vomiting, particularly with initial doses.
• Extravasation Risk: It is a potent vesicant; if it leaks from the vein into surrounding tissue, it can cause severe pain and tissue damage.
• Photosensitivity: Patients should avoid prolonged sun exposure as the drug can make skin highly sensitive to light

Epirubicin 50 mg is a chemotherapy medication in the anthracycline class, primarily used as an adjuvant treatment for patients with breast cancer after surgery. As of 2026, it remains a standard treatment for various malignancies, including stomach, lung, and ovarian cancers. Key Uses and Administration

• Primary Indications: Breast cancer (often in combination chemotherapy), stomach cancer, lung cancer, ovarian cancer, and soft tissue sarcomas.
• Bladder Cancer: It can be administered directly into the bladder (intravesical administration) to treat or prevent the recurrence of bladder cancer.
• Administration: Typically given by a healthcare professional as an intravenous (IV) infusion over 3 to 30 minutes, usually every 3 to 4 weeks.
• Mechanism: It works by blocking DNA and RNA synthesis, effectively stopping the division and growth of cancer cells. 

Common Side Effects

• Blood and Immune System: Low white blood cell counts (increasing infection risk), low platelets (bruising/bleeding), and anemia.
• Digestive and Physical: Nausea, vomiting, hair loss, mouth ulcers, diarrhea, and fatigue.
• Urine Discoloration: This medicine may cause urine to turn a reddish color for 1–2 days after treatment; this is normal and temporary. 

Critical Warnings

• Cardiotoxicity: Epirubicin is known to cause long-term heart damage and can lead to congestive heart failure. Doctors monitor heart function closely during treatment.
• Vesicant Hazard: It is a potent vesicant. If it leaks from the vein during injection, it can cause severe tissue damage or blistering.
• Pregnancy and Fertility: It is unsafe for use during pregnancy and can cause irreversible infertility in both men and women. 

Mitomycin 40 mg is a potent chemotherapy medication used primarily to treat advanced cancers of the stomach, pancreas, breast, and lungs. It belongs to a class of drugs known as antineoplastic antibiotics, which work by damaging the DNA of cancer cells to stop them from dividing and multiplying. Primary UsesMitomycin 40 mg is typically used in combination with other chemotherapy agents for: 

• Gastrointestinal Cancers: Advanced adenocarcinoma of the stomach and pancreas.
• Bladder Cancer: Often administered directly into the bladder (intravesical) after surgery to prevent tumor recurrence.
• Other Cancers: It may be used for breast, lung (non-small cell), cervical, and head/neck cancers. 

Administration

• Method: Mitomycin 40 mg is strictly administered by healthcare professionals, either as an intravenous (IV) infusion into a vein or an intravesical instillation directly into the bladder.
• Schedule: The scheduling of administration is determined by a healthcare professional based on the patient's condition and treatment plan. 

Side Effects and RisksMitomycin is highly toxic and can cause significant side effects that require close medical monitoring: 

• Bone Marrow Suppression: The most serious side effect, leading to a severe decrease in white blood cells (increasing infection risk), red blood cells (anemia), and platelets (increased bleeding).
• Tissue Damage: If the drug leaks from the vein (extravasation) during injection, it can cause severe tissue necrosis (death) and sloughing.
• Organ Toxicity: It can cause long-term damage to the kidneys and lungs. Hemolytic Uremic Syndrome (HUS) is a rare but life-threatening kidney complication.
• Common Effects: Nausea, vomiting, loss of appetite, fatigue, and temporary hair loss. 

Safety Precautions

• Pregnancy: It is highly unsafe and can cause fetal harm; effective contraception is mandatory during treatment.
• Monitoring: Regular blood, liver, and kidney function tests are required throughout the treatment course.
• Driving: It may cause nausea or dizziness that impairs reaction times; avoid driving if affected. 

Mitomycin 10 mg injection is a potent anti-cancer (antineoplastic) medication used primarily in chemotherapy to treat various advanced or metastatic cancers, including those of the stomach, pancreas, breast, and lungs. It works by damaging the DNA of cancer cells, which prevents them from growing and multiplying. Key Uses and Administration

• Targeted Cancers: In 2026, it remains a standard treatment for disseminated adenocarcinoma of the stomach or pancreas, often in combination with other drugs. It is also used for bladder cancer (often administered directly into the bladder) and non-small cell lung cancer.
• Administration: This drug must be administered by a qualified healthcare professional. It is typically given intravenously (into a vein) or intravesically (into the bladder).
• Safety Warning: Mitomycin is highly toxic if it leaks out of the vein (extravasation), which can cause severe tissue death and necrosis. Common Side EffectsAs of 2026, patients are advised that side effects are common due to the drug's impact on healthy cells: 
  • Bone Marrow Suppression: The most serious common effect, leading to low red blood cells (anemia), low white blood cells (increased infection risk), and low platelets (bleeding tendency).
  • Gastrointestinal Issues: Nausea, vomiting, and loss of appetite.
  • Other Effects: Fatigue, temporary hair loss, and potential kidney or lung toxicity with long-term use. 
  Important Precautions
  • Pregnancy & Breastfeeding: It is highly unsafe during pregnancy and can cause birth defects. Breastfeeding should be avoided during and for a period after treatment.
  • Monitoring: Regular blood tests are mandatory to check blood cell counts, as well as liver and kidney function.
  • Vaccinations: Live virus vaccines (e.g., yellow fever) should not be taken during or for at least 3 months after chemotherapy.
  • Driving: It may cause nausea or dizziness, which can impair your ability to drive or operate machinery. 

Doxorubicin 50 mg is a powerful cytotoxic chemotherapy medication belonging to the anthracycline class, primarily used to treat a wide range of cancers by interfering with the DNA of cancer cells. Key Medical UsesDoxorubicin is used alone or in combination with other anti-cancer drugs for conditions including: 

• Solid Tumors: Breast, lung, ovarian, stomach, bladder, and thyroid cancers.
• Blood Cancers: Acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and lymphomas (Hodgkin's and Non-Hodgkin's).
• Other Conditions: Soft tissue and bone sarcomas, neuroblastoma, and Wilms' tumor in children. 

Mechanism of ActionDoxorubicin works by intercalation, a process where it inserts itself into the DNA strands of rapidly dividing cells. This action: 

1. Disrupts the DNA's double helix structure.
2. Suppresses the topoisomerase II enzyme, preventing DNA replication.
3. Forms free radicals that cause further DNA damage, leading to programmed cell death (apoptosis). 

Administration and Dosage

• Method: Administered strictly as an intravenous (IV) infusion by qualified healthcare professionals. Self-administration is strictly prohibited.
• Dosage: For a 50 mg strength, it is typically provided as a 50 mg/25 mL solution (2 mg/mL concentration) or as a lyophilized powder for reconstitution.
• Frequency: Usually given once every 21 to 28 days, though schedules vary based on the specific treatment regimen. 

Critical Safety Warnings

• Cardiotoxicity: Doxorubicin can cause serious, sometimes life-threatening heart problems (e.g., congestive heart failure) even years after treatment ends. Doctors monitor heart function using ECGs or echocardiograms.
• Extravasation Risk: If the drug leaks into surrounding tissue during injection, it can cause severe tissue damage, ulcers, or necrosis.
• Pregnancy & Fertility: It is unsafe during pregnancy and breastfeeding as it may harm the fetus. It can cause temporary or permanent infertility in both men and women.
• Bone Marrow Suppression: It significantly reduces blood cell counts (white cells, red cells, and platelets), increasing the risk of serious infections and bleeding. 

Storage

• Must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Do not freeze.
• The medication is photosensitive and should be protected from light

Bortezomib injection (2 mg) is a targeted anti-cancer medication primarily used to treat multiple myeloma (a type of bone marrow cancer) and mantle cell lymphoma (a rare type of non-Hodgkin lymphoma). It is a proteasome inhibitor that works by blocking the breakdown of proteins in cells, leading to an accumulation of proteins that eventually triggers the death of cancer cells. Key Information for 2026

• Administration: It must be administered by a qualified healthcare professional as either an intravenous (IV) injection into a vein or a subcutaneous (SC) injection under the skin. Self-administration is not recommended unless specifically trained and supervised under a structured home-care plan.
• Common Brand Names (India): Bortenat (Natco), Myezom (Dr. Reddy’s), Borviz (Intas), and Bortecad (Zydus).
• Estimated Price: Prices vary widely by brand and retailer. In early 2026, 2 mg vials typically range from approximately ₹500 to ₹3,500 per injection, depending on the manufacturer and discounts. 

Side Effects & Safety

• Common Side Effects: Fatigue, nausea, vomiting, diarrhea, loss of appetite, and constipation.
• Serious Risks:
  • Nerve Damage: Peripheral neuropathy (tingling, numbness, or pain in hands and feet) is a significant side effect.
  • Blood Counts: It can significantly lower red blood cells (anemia), white blood cells (neutropenia), and platelets (thrombocytopenia), increasing the risk of infection and bleeding.
• Precautions:
  • Pregnancy & Breastfeeding: Unsafe for use; effective contraception is required for both men and women during and for at least 3–6 months after treatment.
  • Liver/Kidney Disease: Requires caution and potential dose adjustments by a doctor.
  • Storage: Unopened vials should typically be stored in a refrigerator (2°C to 8°C) and protected from light. 

Paclitaxel 100 mg is a chemotherapy medication used to treat several types of cancer by interfering with the growth and spread of cancer cells. It is a member of the taxane class of drugs and works by stabilizing microtubule structures, which prevents cancer cells from dividing and eventually leads to their death. Common UsesIt is primarily used for the following conditions: 

• Breast Cancer: Often used after surgery (adjuvant) or for advanced/metastatic stages.
• Ovarian Cancer: Frequently used as a first-line treatment, often in combination with other drugs like cisplatin.
• Non-Small Cell Lung Cancer (NSCLC): For patients who are not candidates for surgery or radiation.
• Pancreatic Cancer: Used to control growth and relieve symptoms.
• AIDS-Related Kaposi's Sarcoma: Indicated when other treatments have not been effective. 

Administration

• Method: Administered exclusively by intravenous (IV) infusion in a hospital or clinic setting by trained medical professionals.
• Schedule: Typically given over 1 to 3 hours, either once every three weeks or in lower doses weekly, depending on the specific cancer type.
• Premedication: Patients are often given steroids (like dexamethasone) and antihistamines before the infusion to prevent severe allergic reactions. 

Common Side EffectsMost side effects are due to the drug's effect on fast-growing healthy cells: 

• Blood Counts: Low white blood cell count (neutropenia), low red blood cells (anemia), and low platelets, which can increase infection and bleeding risks.
• Nerve Issues: Peripheral neuropathy, characterized by tingling, numbness, or pain in the hands and feet.
• Physical Changes: Complete hair loss (usually temporary), nausea, vomiting, and mouth sores.
• Body Aches: Muscle and joint pain (sometimes called taxane acute pain syndrome), typically occurring 2–3 days after treatment. 

Zoledronic acid 4 mg is a potent intravenous bisphosphonate medication used to manage and treat conditions characterized by excessive bone breakdown or dangerously high blood calcium levels, often associated with cancer. 1. Common Uses (Indications)

• Hypercalcemia of Malignancy (TIH): Treats life-threateningly high calcium levels in the blood caused by tumors.
• Multiple Myeloma & Bone Metastases: Prevents "skeletal-related events" like fractures and severe bone pain in patients whose cancer (e.g., breast or prostate) has spread to the bones.
• Osteoporosis: In both men and postmenopausal women, it helps strengthen bones and reduce fracture risk.
• Paget’s Disease of Bone: Normalizes abnormal bone remodeling to relieve pain and prevent deformities. 

2. Administration and Dosage

• Method: Administered only by healthcare professionals as an intravenous (IV) infusion.
• Duration: The infusion must last at least 15 minutes; faster administration significantly increases the risk of kidney damage.
• Frequency:
  • Cancer-related bone damage: Typically once every 3 to 4 weeks.
  • Hypercalcemia: Usually a single dose, which may be repeated after at least 7 days if calcium remains high.
• Hydration: Patients must drink plenty of fluids (at least 2 glasses of water before and after) to prevent kidney strain. 

3. Common Side Effects

• Acute Phase Reaction: Often called "flu-like symptoms," including fever, chills, fatigue, and bone or muscle pain, typically occurring within 3 days of the infusion.
• Gastrointestinal: Nausea, vomiting, diarrhea, or constipation.
• Hypocalcemia: Low blood calcium levels, which can cause muscle cramps or tingling in the hands and feet. 

4. Serious Warnings and Precautions

• Kidney Toxicity: Can lead to acute renal failure; kidney function (serum creatinine) must be tested before every dose.
• Osteonecrosis of the Jaw (ONJ): A rare but serious condition where jawbone tissue dies, often following dental work. A dental exam is recommended before starting treatment.
• Atypical Femur Fractures: Rare reports of thigh bone fractures occurring with minimal trauma.
• Contraindications: Should not be used during pregnancy or breastfeeding, or by patients with severe kidney disease or uncorrected low calcium.